BRIEF published on 05/06/2024 at 19:25, 2 years 3 months ago Araceli Biosciences Welcomes New CEO Matt Beaudet Innovation Biotechnology CEO Appointment Leadership Matt Beaudet
PRESS RELEASE published on 05/06/2024 at 19:20, 2 years 3 months ago Araceli Biosciences Introduces Matt Beaudet as New President and Chief Executive Officer Araceli Biosciences appoints Matthew Beaudet as CEO, bringing over two decades of biotech industry experience. Board confident in his leadership for company growth and innovation CEO Appointment Biotech Industry Company Growth Matt Beaudet Araceli Biosciences
Published on 08/31/2026 at 22:00, 6 minutes ago NV Gold Announces Closing of First Tranche of Non-Brokered Private Placement
Published on 08/31/2026 at 17:22, 4 hours 44 minutes ago ACCESS Newswire Expands the Marketplace with Two New Partners: TVEyes and Listicle Liaison
Published on 08/31/2026 at 15:50, 6 hours 16 minutes ago Sarama Resources - Grant of Equity Incentives
Published on 08/31/2026 at 15:00, 7 hours 6 minutes ago Super Copper Featured at OTC Markets' Virtual Investor Conference, Presentation Replay Now Available
Published on 08/31/2026 at 19:31, 2 hours 35 minutes ago DEAG reports strong results for the first half of 2026
Published on 08/31/2026 at 19:15, 2 hours 51 minutes ago CGTN: How China-Kyrgyzstan 'golden' ties deliver for both nations and the region
Published on 08/31/2026 at 18:20, 3 hours 46 minutes ago CPI PROPERTY GROUP publishes financial results for the first half of 2026
Published on 08/31/2026 at 18:06, 4 hours ago MELLENU HOLDING S.A. REPORTS RESULTS FOR THE SIX MONTHS ENDING 30 JUNE 2026
Published on 08/31/2026 at 18:04, 4 hours 1 minute ago PRIMARY HYDROGEN EXPANDS CUMBERLAND BASIN POSITION WITH STAKING OF THE WALLACE PROJECT, NOVA SCOTIA
Published on 08/31/2026 at 17:45, 4 hours 21 minutes ago Disclosure of transactions in own shares from August 24 to August 28, 2026
Published on 08/31/2026 at 12:00, 10 hours 6 minutes ago Capital increase through exercise of subscription rights
Published on 08/31/2026 at 07:00, 15 hours 6 minutes ago Biophytis strengthens its financial position and extends its cash runway into Q1 2027
